Newest added products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25149 | Safusidenib | 1898206-17-1 | ≧98.0% |  |
| Safusidenib, also known as DS-1001, is an oral isocitrate dehydrogenase [NADP] cytopl | ||||
| 237072 | AZD0095 | 2750001-23-9 | ≧98.0% |  |
| AZD0095 is a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. | ||||
| 20577 | LY-3522348 | 2568608-48-8 | ≧98.0% |  |
| LY-3522348 is a ketohexokinase (KHK) inhibitor. | ||||
| 24069 | Tuvusertib | 1613200-51-3 | ≧98.0% |  |
| Tuvusertib, also known as M-1774 and ATR inhibitor 1, is a ATR inhibitor. M1774 selec | ||||
| 24129 | 2-MNG | 2101538-28-5 | ≧98.0% |  |
| 2-MNG is a new potent melanogenesis inhibitor, which exhibits a unique mode of action | ||||
| 25091 | Rilzabrutinib ( PRN1008 ) | 1575591-66-0 | ≧98.0% | _1575591-66-0.png) |
| Rilzabrutinib ( PRN1008 ) is an oral, reversible, covalent, small-molecule inhibitor | ||||
| 25147 | MAT2A-IN-9 ( GSK4362676 ) | 2439277-80-0 | ≧98.0% |  |
| MAT2A-IN-9 ( GSK4362676 ), is a 2-oxoquinazoline derivative, is a potent MAT2A (methi | ||||
| 25150 | Ranosidenib | 2301974-60-5 | ≧98.0% |  |
| Ranosidenib, also known as HMPL-306, is an isocitrate dehydrogenase (IDH) inhibitor. | ||||
| 25171 | Alnodesertib ( Synonyms: ART0380 ) | 2267316-76-5 | ≧98.0% | .png) |
| 25172 | Amcasertib (Synonyms: BBI503) | 1129403-56-0 | ≧98.0% | _1129403-56-0.png) |
| 25173 | Anatibant (Synonyms: LF 16-0687; XY-2405) | 209733-45-9 | ≧98.0% | _209733-45-9.png) |
| 25174 | Catadegbrutinib (Synonyms: BGB-16673; BTK-IN-29) | 2736508-60-2 | ≧98.0% | _2736508-60-2.png) |